La chaîne d'options affiche les données clés des options sur actions de BriaCell Therapeutics à différents prix d'exercice et dates d'expiration. Les traders utilisent ces informations pour analyser les transactions potentielles et évaluer le sentiment du marché pour BriaCell Therapeutics..

BriaCell Therapeutics (NASDAQ:BCTX) Stock, Chaîne d'Options

BriaCell Therapeutics

BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an entirely new class of targeted immunotherapies to transform cancer care. Its product candidate Bria-IMT, is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC is breast cancer that has spread to other tissues). Bria-IMT is a targeted cell-based immunotherapy. The company is engaged in developing a Bria-OTS platform of personalized off-the-shelf cell-based immunotherapies. It is being evaluated in a Phase 1/2 clinical study and the treatment is initially focused on patients with breast cancer with an extension to prostate cancer, and other cancers.

BriaCell Therapeutics Corp. - Common Shares

BriaCell Therapeutics Corp

Kevin O'Leary thinks the biggest reason people wait to have kids is simple—money.
&#8220;The reason people don&#8217;t have kids earlier is they&#8217;re expensive,&#8221; the investor and TV personality said during a recent Fox News <a href="https://x.com/kevinolearytv/status/1914441467189219356">interview</a> he shared on X. He tied the trend of delayed parenthood to rising living costs and the sky-high price of education. &#8220;So we&#8217;ve got a few things to fix ourselves,&#8221; he added.
Don't Miss:
<ul>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.26/share with a $1000 minimum.</a></li>
<li>The average American couple has saved this much money for retirement —<a href="http://www.benzinga.com/money/smartasset"> How do you compare</a>?</li>
</ul>
<h2 class="wp-block-heading">Waiting Longer to Start Families</h2>
O'Leary reflected on his own life and said he wishes he had his children sooner. &#8220;What you learn in life is, when you get older, you realize you wish you had your kids earlier,&#8221; he said. &#8220;Family is the best thing you can get in America. If I could go back in time, I would have had them a decade earlier.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The reason people don&#39;t have kids earlier is they&#39;re expensive. This is kind of an issue around the cost of living and the price of education. So we&#39;ve got a few things to fix. We&#39;re in a very interesting situation now because people are waiting longer. What you learn in life is,… <a href="https://t.co/Hm29chkcRI">pic.twitter.com/Hm29chkcRI</a>
&mdash; Kevin O&#39;Leary aka Mr. Wonderful (@kevinolearytv) <a href="https://twitter.com/kevinolearytv/status/1914441467189219356?ref_src=twsrc%5Etfw">April 21, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
During the interview, he was asked about policies like baby bonuses and fertility incentives, which the Trump administration has floated as ways to boost the U.S. birth rate. O'Leary didn't offer strong support or opposition but brought up a familiar name: Elon Musk.
&#8220;I think Elon&#8217;s doing a great job making up for the rest of us,&#8221; he joked. &#8220;I think he&#8217;s on kid 14 now. Good for him.&#8221;
Trending: BlackRock is calling 2025 the year of alternative assets. <a href="https://www.benzinga.com/money/masterworks">One firm from NYC has quietly built a group of 60,000+ investors who have all joined in on an alt asset class previously exclusive to billionaires like Bezos and Gates.</a>
<h2 class="wp-block-heading">The Real Costs of Raising Kids</h2>
O'Leary's comments reflect a <a href="https://www.benzinga.com/personal-finance/25/01/42805973/300000-and-counting-the-cost-of-a-decision-many-parents-regret">real financial hurdle</a> for many Americans. According to <a href="https://www.brookings.edu/wp-content/uploads/2022/08/Brookings_Cost-to-raise-a-child_inflation-adjusted-2.pdf">data</a> from the Brookings Institution, it now costs an average of $310,605 to raise a child from birth to age 17 for a middle-income family with two kids.
That's a big jump from the U.S. Department of Agriculture's 2015 <a href="https://www.fns.usda.gov/cnpp/2015-expenditures-children-families">estimate</a> of $233,610. The difference is largely due to increases in housing, childcare, food, and education.
According to <a href="https://www.investopedia.com/articles/personal-finance/090415/cost-raising-child-america.asp">Investopedia</a>, housing alone can eat up 32% of a household's income, based on consumer expenditures data. Food can take up 15% to 24%, depending on diet and family size. And childcare? That ranges from 7% to 23%, depending on where you live and what type of care you need.
And this doesn't even include the cost of college. A year at a public university now averages $24,920, while private colleges can run over $58,000 per year.
See Also: Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">invest pre-IPO from $0.60 per share now</a>.
<h2 class="wp-block-heading">Looking for Relief</h2>
Families can look for tax credits like the <a href="https://www.benzinga.com/personal-finance/25/03/44124166/affordable-childcare-act-could-give-parents-up-to-12k-but-can-it-pass-a-divided-congress">child tax credit</a> or explore <a href="https://www.benzinga.com/money/best-529-plans">529 college savings plans</a> to make things more manageable. But even with those tools, the numbers add up quickly.
That's why O'Leary's message resonates: it's not about people not wanting kids, it's about whether they can afford them.
&#8220;We're in a very interesting situation now because people are waiting longer,&#8221; he said. And as many parents later realize, time is the one thing money can't buy.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a></li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
</ul>
Image: Shutterstock

News

'Reason People Don't Have Kids Earlier Is They're Expensive,' Says Kevin O'Leary. However, 'Time Is The One Thing Money Can't Buy'

Having kids used to be something people did in their 20s. Now, it's starting to look more like a midlife milestone.
For the first time ever, more Americans over 40 are giving birth than teenagers. The average age for first-time mothers has hit a record high of 27.5, <a href="https://www.cdc.gov/nchs/data/nvsr/nvsr72/nvsr72-01.pdf#3">according to the Centers for Disease Control and Prevention</a>, and experts say cost is a big reason people are putting off parenthood. But <a href="https://www.benzinga.com/personal-finance/25/04/44887160/kevin-oleary-says-500000-is-the-magic-number-to-live-comfortably-you-can-live-off-half-a-million-bucks-and-do-nothing-else-to-make-money">Kevin O'Leary</a> thinks that delay may come with regret — and says Elon Musk is doing what most Americans aren't.
Don't Miss:
<ul>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
<li>The average American couple has saved this much money for retirement —<a href="http://www.benzinga.com/money/smartasset"> How do you compare</a>?</li>
</ul>
O'Leary <a href="https://x.com/kevinolearytv/status/1914441467189219356">posted</a> a message on X that was part reflection, part economic reality check. "The reason people don't have kids earlier is they're expensive," he wrote. "This is kind of an issue around the cost of living and the price of education. So we've got a few things to fix."
Attached to the post was a clip from a recent Fox News segment. In it, O'Leary was asked about President Donald Trump's pitch for baby bonuses and a New York Times headline that said the idea was to "persuade women to have kids." His response? "It's interesting," he said. "I think Elon is doing a great job making up for the rest of us. I think he's on kid 14 now."
He doubled down in the clip: "At the end of the day, the reason people don't have kids here — they're expensive." O'Leary pointed to the cost of education, housing, and childcare, calling it a system that's not optimized for young families.
Trending: It&#8217;s no wonder Jeff Bezos holds over $250 million in art — <a href="https://www.benzinga.com/money/masterworks">this alternative asset has outpaced the S&amp;P 500 since 1995, delivering an average annual return of 11.4%. Here&#8217;s how everyday investors are getting started.</a>
He also tied the issue to broader global concerns, noting that even countries like China have struggled with population planning. "Even the Chinese for a while started to think, ‘Wait a second, how do we feed all these people?' And it goes back to the tariff wars."
But the most personal part came when O'Leary turned inward. "We are in a very interesting situation now because people are waiting longer," he said. "And what you learn in life, which is kind of crazy, is when you get older, you realize you wish you had your kids earlier."
"Family is the best thing you can get in America," he said. "If I could go back in time, I would have had them a decade earlier."
See Also: <a href="https://www.benzinga.com/money/elon-musk-told-the-u-n-if-they-could-show-a-plan-for-ending-world-hunger-hed-donate-6-billion-i-will-sell-tesla-stock-right-now-and-do-it">Elon Musk Told The U.N. If They Could Show A Plan For Ending World Hunger He'd Donate $6 Billion – ‘I Will Sell Tesla Stock Right Now And Do It'</a>
The <a href="https://www.benzinga.com/personal-finance/24/11/42190349/the-u-s-birthrate-has-plunged-53-since-1960-an-hsbc-economist-is-sounding-the-alarm">stats echo the trend</a>: births to teens in the U.S. have dropped 78% since 1991, while births to people over 40 have steadily climbed, <a href="https://www.pewresearch.org/social-trends/2018/01/18/theyre-waiting-longer-but-u-s-women-today-more-likely-to-have-children-than-a-decade-ago/">according to Pew Research</a>. Fertility treatments and financial planning may play a role, but many simply feel they can't afford kids in their 20s.
Still, O'Leary's message cuts through the economic fog: if you wait until everything is "affordable," you might be waiting forever. And while Musk's massive family may not be for everyone, O'Leary's point is clear — delayed parenthood may make financial sense, but it comes at a personal cost.
Read Next:
<ul>
<li>Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">invest pre-IPO from $0.60 per share now</a>.</li>
<li><a href="https://www.benzinga.com/money/mark-cubans-advice-for-lotto-winners">Many are surprised by Mark Cuban's advice for lotto winners: Cash or annuity?</a></li>
</ul>
Image: Shutterstock

Personal Finance

Kevin O' Leary Says People Are Waiting Longer To Have Kids Due To Cost Of Living, But 'Elon Musk Is Making Up For The Rest Of Us' With 14 Kids

Extra Space Storage (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EXR#NYSE">EXR</a>) has outperformed the market over the past 20 years by 4.66% on an annualized basis producing an average annual return of 12.69%. Currently, Extra Space Storage has a market capitalization of $30.13 billion. 
Buying $1000 In EXR: If an investor had bought $1000 of EXR stock 20 years ago, it would be worth $10,912.31 today based on a price of $141.99 for EXR at the time of writing.
<h3>Extra Space Storage's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745538311_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

Here's How Much You Would Have Made Owning Extra Space Storage Stock In The Last 20 Years

WIIM

DGICA

DGICA stock has given up its prior gain. Donegal Group shares were trading higher after the company reported better-than-expected Q1 adjusted EPS results.

Quest Diagnostics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DGX#NYSE">DGX</a>) has outperformed the market over the past 5 years by 290.7% on an annualized basis producing an average annual return of 304.55%. Currently, Quest Diagnostics has a market capitalization of $19.69 billion. 
Buying $1000 In DGX: If an investor had bought $1000 of DGX stock 5 years ago, it would be worth $1,149,477.12 today based on a price of $175.87 for DGX at the time of writing.
<h3>Quest Diagnostics's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745536510_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning Quest Diagnostics Stock In The Last 5 Years

PDD Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDD#NASDAQ">PDD</a>) has outperformed the market over the past 5 years by 2.67% on an annualized basis producing an average annual return of 16.53%. Currently, PDD Holdings has a market capitalization of $143.47 billion. 
Buying $1000 In PDD: If an investor had bought $1000 of PDD stock 5 years ago, it would be worth $2,017.39 today based on a price of $103.31 for PDD at the time of writing.
<h3>PDD Holdings's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745535617_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Citigourp Global Markets 2% Protected Notes Linked To The Djia

Here's How Much $1000 Invested In PDD Holdings 5 Years Ago Would Be Worth Today

Lockheed Martin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>) has outperformed the market over the past 15 years by 1.32% on an annualized basis producing an average annual return of 12.03%. Currently, Lockheed Martin has a market capitalization of $109.37 billion. 
Buying $100 In LMT: If an investor had bought $100 of LMT stock 15 years ago, it would be worth $540.48 today based on a price of $466.81 for LMT at the time of writing.
<h3>Lockheed Martin's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745534712_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning Lockheed Martin Stock In The Last 15 Years

Tariff policies and plans by the Trump administration are <a href="https://www.benzinga.com/topic/tariffs">not being well received</a> by many consumers in the U.S. and people around the world.
A British billionaire is the latest to speak out on the negative impact the tariffs could have on global economics.
What Happened: Billionaire Richard Branson, best known for the Virgin Group and subsidies, is not being quiet when it comes to speaking out about President Donald <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/04/44961882/iphone-resecue-apple-tariff-worries">Trump's tariff plans.</a>
"He's in danger of doing so much damage in the world. It's just sad, incredibly sad," Branson said earlier this week while boarding a Virgin Atlantic flight, as reported by The Times.
Branson said Trump is "in danger of doing so much damage" to the world with his tariff policies.
"The world was on the verge of a complete meltdown two weeks ago."
The billionaire said Trump's tariff decisions "have financially done a lot of harm."
With Trump backtracking on some tariff plans, Branson said the president's policymaking is showing signs of being "erratic."
"The unpredictability is just awful for everybody around the world."
Branson said people are delaying decisions on investment and spending with the unpredictability caused by Trump worldwide.
The billionaire said companies will "manage as we always do" to fight on in the tariff era. Branson said his cruise ships and airlines were booming before the trade war caused "a bit of softness in the U.S."
Branson said the softness for Virgin Atlantic for flights from the U.S. to Europe has partially been offset by Virgin's new route from Toronto to London and Canadians upset by Trump's tariffs and his "51st state" label placed on Canada.
"Canadians are flooding the U.K. and are not going to America."
Read Also: <a href="https://www.benzinga.com/25/01/43156951/billionaire-richard-branson-criticizes-trumps-decision-to-withdraw-from-paris-climate-deal-powering-the-world-with-clean-energy-is-common-sense">Billionaire Richard Branson Criticizes Trump&#8217;s Decision To Withdraw From Paris Climate Deal: &#8216;Powering The World With Clean Energy Is Common Sense&#8217;</a>
More Criticism: Along with criticizing Trump's tariff policies, Branson also took exception to the U.S., led by Trump, deciding to "jump side" on Ukraine in their fight with Russia.
Branson said this put the U.S. on the wrong side of history and "should worry the world the most."
The billionaire said it could be a "fairly small elite of people" around the president causing the U-turn on Ukraine.
"I don't think he's carrying the vast majority of Americans in what he's doing. Most American people are decent individuals. Many Americans I know are just very sad."
Branson asked if Trump will "abide by the treaty America signed in 1994" and support Ukraine. The billionaire said if America won't support Ukraine, Europe needs to step up.
"We've got to ramp up weapons supplies, like we haven't done since the Second World War."
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/space/24/07/39655161/billionaire-wakes-up-to-find-elon-musk-barefoot-in-his-kitchen-we-made-a-pot-of-tea-and-sat-outside">Billionaire Wakes Up To Find Elon Musk Barefoot In His Kitchen: &#8216;We Made A Pot Of Tea And Sat Outside Under The Stars&#8217;</a></li>
</ul>
Photo: <a href="https://www.shutterstock.com/g/sergeibach">Sergei Bachlakov</a> via Shutterstock

Politics

Travel

Global

Billionaire Richard Branson Criticizes Trump's Tariff Decisions: 'World Was On The Verge Of A Complete Meltdown'

Arthur J. Gallagher (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AJG#NYSE">AJG</a>) has outperformed the market over the past 15 years by 7.7% on an annualized basis producing an average annual return of 18.41%. Currently, Arthur J. Gallagher has a market capitalization of $86.77 billion. 
Buying $100 In AJG: If an investor had bought $100 of AJG stock 15 years ago, it would be worth $1,248.19 today based on a price of $339.31 for AJG at the time of writing.
<h3>Arthur J. Gallagher's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745533810_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In Arthur J. Gallagher 15 Years Ago Would Be Worth This Much Today

First Savings Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSFG#NASDAQ">FSFG</a>) reported quarterly earnings of $0.76 per share which beat the analyst consensus estimate of $0.59 by 28.81 percent. This is a 46.15 percent increase over earnings of $0.52 per share from the same period last year.

Earnings

Earnings Beats

FSFG

First Savings Financial Q2 Adj. EPS $0.76 Beats $0.59 Estimate

General

FCPT

FCPT Acquires A Caribou Coffee Property For $1.4M

L3Harris Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LHX#NYSE">LHX</a>) has outperformed the market over the past 20 years by 2.63% on an annualized basis producing an average annual return of 10.66%. Currently, L3Harris Technologies has a market capitalization of $40.60 billion. 
Buying $1000 In LHX: If an investor had bought $1000 of LHX stock 20 years ago, it would be worth $7,642.05 today based on a price of $216.27 for LHX at the time of writing.
<h3>L3Harris Technologies's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745532911_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In L3Harris Technologies 20 Years Ago Would Be Worth This Much Today

<a href="https://www.bloomberg.com/news/articles/2025-04-24/apollo-s-yahoo-ready-to-buy-if-google-must-sell-chrome-browser">https://www.bloomberg.com/news/articles/2025-04-24/apollo-s-yahoo-ready-to-buy-if-google-must-sell-chrome-browser</a>

GOOG

GOOGL

'Yahoo Is Ready to Buy Chrome Browser If Google Is Forced to Sell'- Bloomberg

UBS analyst Gregg Orrill downgrades American Water Works Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AWK#NYSE">AWK</a>) from Buy to Neutral and announces $160 price target.

Downgrades

Price Target

Analyst Ratings

UBS Downgrades American Water Works Co to Neutral, Announces $160 Price Target

Maxim Group analyst Allen Klee initiates coverage on Castellum (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CTM#AMEX">CTM</a>) with a Buy rating and announces Price Target of $3.

Initiation

Maxim Group Initiates Coverage On Castellum with Buy Rating, Announces Price Target of $3

In the last three months, 25 analysts have published ratings on DraftKings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DKNG#NASDAQ">DKNG</a>), offering a diverse range of perspectives from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">15</td>
<td align="right">10</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">5</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">8</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $56.88, along with a high estimate of $65.00 and a low estimate of $50.00. Marking an increase of 3.34%, the current average surpasses the previous average price target of $55.04. 
<img src="https://www.benzinga.com/files/images/story/2025/1745532061_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
The standing of DraftKings among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;------------------------&#x7C;---------------&#x7C;-----------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Lance Vitanza &#x7C;TD Securities &#x7C;Lowers &#x7C;Buy &#x7C; $55.00&#x7C;$60.00 &#x7C; 
&#x7C;Barry Jonas &#x7C;Truist Securities &#x7C;Lowers &#x7C;Buy &#x7C; $50.00&#x7C;$60.00 &#x7C; 
&#x7C;Brandt Montour &#x7C;Barclays &#x7C;Lowers &#x7C;Overweight &#x7C; $50.00&#x7C;$60.00 &#x7C; 
&#x7C;Jeffrey Stantial &#x7C;Stifel &#x7C;Lowers &#x7C;Buy &#x7C; $53.00&#x7C;$57.00 &#x7C; 
&#x7C;Clark Lampen &#x7C;BTIG &#x7C;Lowers &#x7C;Buy &#x7C; $52.00&#x7C;$64.00 &#x7C; 
&#x7C;Curry Baker &#x7C;Guggenheim &#x7C;Lowers &#x7C;Buy &#x7C; $61.00&#x7C;$62.00 &#x7C; 
&#x7C;Bernie McTernan &#x7C;Needham &#x7C;Maintains &#x7C;Buy &#x7C; $65.00&#x7C;$65.00 &#x7C; 
&#x7C;Jordan Bender &#x7C;Citizens Capital Markets&#x7C;Lowers &#x7C;Market Outperform&#x7C; $57.00&#x7C;$60.00 &#x7C; 
&#x7C;Jordan Bender &#x7C;Citizens Capital Markets&#x7C;Maintains &#x7C;Market Outperform&#x7C; $60.00&#x7C;$60.00 &#x7C; 
&#x7C;Mike Hickey &#x7C;Benchmark &#x7C;Raises &#x7C;Buy &#x7C; $51.00&#x7C;$44.00 &#x7C; 
&#x7C;Stephen Grambling &#x7C;Morgan Stanley &#x7C;Raises &#x7C;Overweight &#x7C; $53.00&#x7C;$49.00 &#x7C; 
&#x7C;Joseph Greff &#x7C;JP Morgan &#x7C;Raises &#x7C;Overweight &#x7C; $61.00&#x7C;$53.00 &#x7C; 
&#x7C;Jordan Bender &#x7C;JMP Securities &#x7C;Raises &#x7C;Market Outperform&#x7C; $60.00&#x7C;$50.00 &#x7C; 
&#x7C;Daniel Politzer &#x7C;Wells Fargo &#x7C;Raises &#x7C;Overweight &#x7C; $60.00&#x7C;$53.00 &#x7C; 
&#x7C;Matt Farrell &#x7C;Piper Sandler &#x7C;Raises &#x7C;Overweight &#x7C; $60.00&#x7C;$48.00 &#x7C; 
&#x7C;Brandt Montour &#x7C;Barclays &#x7C;Raises &#x7C;Overweight &#x7C; $60.00&#x7C;$50.00 &#x7C; 
&#x7C;Barry Jonas &#x7C;Truist Securities &#x7C;Raises &#x7C;Buy &#x7C; $60.00&#x7C;$50.00 &#x7C; 
&#x7C;Jeffrey Stantial &#x7C;Stifel &#x7C;Raises &#x7C;Buy &#x7C; $57.00&#x7C;$48.00 &#x7C; 
&#x7C;Bernie McTernan &#x7C;Needham &#x7C;Raises &#x7C;Buy &#x7C; $65.00&#x7C;$60.00 &#x7C; 
&#x7C;Mike Hickey &#x7C;Benchmark &#x7C;Raises &#x7C;Buy &#x7C; $51.00&#x7C;$44.00 &#x7C; 
&#x7C;Jordan Bender &#x7C;JMP Securities &#x7C;Maintains &#x7C;Market Outperform&#x7C; $50.00&#x7C;$50.00 &#x7C; 
&#x7C;Michael Graham &#x7C;Canaccord Genuity &#x7C;Raises &#x7C;Buy &#x7C; $60.00&#x7C;$54.00 &#x7C; 
&#x7C;Bernie McTernan &#x7C;Needham &#x7C;Maintains &#x7C;Buy &#x7C; $60.00&#x7C;$60.00 &#x7C; 
&#x7C;Bernie McTernan &#x7C;Needham &#x7C;Maintains &#x7C;Buy &#x7C; $60.00&#x7C;$60.00 &#x7C; 
&#x7C;Lance Vitanza &#x7C;TD Cowen &#x7C;Lowers &#x7C;Buy &#x7C; $51.00&#x7C;$55.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to DraftKings. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of DraftKings compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of DraftKings's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
To gain a panoramic view of DraftKings's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/DKNG/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on DraftKings analyst ratings.</a>
<h2>About DraftKings</h2>
DraftKings got its start in 2012 as an innovator in daily fantasy sports. Then, following a Supreme Court ruling in 2018 that allowed states to legalize online sports wagering, the company expanded into online sports and casino gambling, where it generally holds the number two or three revenue share position across states in which it competes. DraftKings is now live with online or retail sports betting in about 25 states and iGaming in five states, with both products available to around 40% of Canada's population. In 2024, sports revenue was 61% of total sales, i-gaming 32%, and fantasy and lottery 7%. The company also operates a non-fungible token commissioned-based marketplace and develops and licenses online gaming products.
<h3>DraftKings's Economic Impact: An Analysis</h3>
Market Capitalization Highlights: Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.
Revenue Growth: DraftKings displayed positive results in 3M. As of 31 December, 2024, the company achieved a solid revenue growth rate of approximately 13.15%. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Consumer Discretionary sector.
Net Margin: DraftKings's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of -9.68%, the company may face hurdles in effective cost management.
Return on Equity (ROE): DraftKings's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of -12.92%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of -3.15%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 1.32.
<h2>Analyst Ratings: What Are They?</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

DKNG

A Glimpse Into The Expert Outlook On DraftKings Through 25 Analysts

In the preceding three months, 8 analysts have released ratings for Ares Capital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARCC#NASDAQ">ARCC</a>), presenting a wide array of perspectives from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">7</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $22.94, a high estimate of $24.50, and a low estimate of $21.00. Experiencing a 0.52% decline, the current average is now lower than the previous average price target of $23.06. 
<img src="https://www.benzinga.com/files/images/story/2025/1745532052_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
A comprehensive examination of how financial experts perceive Ares Capital is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;-----------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Melissa Wedel &#x7C;JP Morgan &#x7C;Lowers &#x7C;Overweight &#x7C; $22.00&#x7C;$24.50 &#x7C; 
&#x7C;Doug Harter &#x7C;UBS &#x7C;Lowers &#x7C;Neutral &#x7C; $21.00&#x7C;$22.00 &#x7C; 
&#x7C;Paul Johnson &#x7C;Keefe, Bruyette &amp; Woods&#x7C;Lowers &#x7C;Outperform &#x7C; $22.00&#x7C;$23.00 &#x7C; 
&#x7C;Kenneth Lee &#x7C;RBC Capital &#x7C;Raises &#x7C;Outperform &#x7C; $24.00&#x7C;$23.00 &#x7C; 
&#x7C;Paul Johnson &#x7C;Keefe, Bruyette &amp; Woods&#x7C;Raises &#x7C;Outperform &#x7C; $23.00&#x7C;$22.00 &#x7C; 
&#x7C;Finian O'Shea &#x7C;Wells Fargo &#x7C;Lowers &#x7C;Overweight &#x7C; $23.00&#x7C;$24.00 &#x7C; 
&#x7C;Melissa Wedel &#x7C;JP Morgan &#x7C;Raises &#x7C;Overweight &#x7C; $24.50&#x7C;$23.00 &#x7C; 
&#x7C;Timothy O'Shea &#x7C;Wells Fargo &#x7C;Raises &#x7C;Overweight &#x7C; $24.00&#x7C;$23.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Ares Capital. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Ares Capital compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Ares Capital's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Ares Capital's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/ARCC/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Ares Capital analyst ratings.</a>
<h2>Delving into Ares Capital's Background</h2>
Ares Capital Corp is a United States-based closed-ended specialty finance company. Its investment objective is to generate both current income and capital appreciation through debt and equity investments. The company focuses on investing primarily in first lien senior secured loans (including unitranche loans, which are loans that combine both senior and subordinated debt, generally in a first lien position) and second lien senior secured loans. In addition to senior secured loans, the company also invests in subordinated loans and preferred equity, it also makes common equity investments.
<h3>Ares Capital: Financial Performance Dissected</h3>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Decline in Revenue: Over the 3M period, Ares Capital faced challenges, resulting in a decline of approximately -11.49% in revenue growth as of 31 December, 2024. This signifies a reduction in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Financials sector.
Net Margin: Ares Capital's net margin is impressive, surpassing industry averages. With a net margin of 90.84%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Ares Capital's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 2.73%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Ares Capital's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 1.29%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 1.03.
<h2>Analyst Ratings: Simplified</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ARCC

Where Ares Capital Stands With Analysts

During the last three months, 4 analysts shared their evaluations of Discover Financial servs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DFS#NYSE">DFS</a>), revealing diverse outlooks from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Discover Financial servs, presenting an average target of $198.5, a high estimate of $262.00, and a low estimate of $129.00. Highlighting a 6.81% decrease, the current average has fallen from the previous average price target of $213.00. 
<img src="https://www.benzinga.com/files/images/story/2025/1745532042_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
A comprehensive examination of how financial experts perceive Discover Financial servs is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Moshe Orenbuch &#x7C;TD Securities &#x7C;Lowers &#x7C;Buy &#x7C; $184.00&#x7C;$188.00 &#x7C; 
&#x7C;Richard Shane &#x7C;JP Morgan &#x7C;Lowers &#x7C;Neutral &#x7C; $129.00&#x7C;$169.00 &#x7C; 
&#x7C;Brian Foran &#x7C;Truist Securities &#x7C;Lowers &#x7C;Buy &#x7C; $219.00&#x7C;$262.00 &#x7C; 
&#x7C;Brian Foran &#x7C;Truist Securities &#x7C;Raises &#x7C;Buy &#x7C; $262.00&#x7C;$233.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Discover Financial servs. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Discover Financial servs compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Discover Financial servs's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Discover Financial servs's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/DFS/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Discover Financial servs analyst ratings.</a>
<h2>Delving into Discover Financial servs's Background</h2>
Discover Financial Services is a bank operating in two distinct segments: direct banking and payment services. The company issues credit and debit cards and provides other consumer banking products including deposit accounts and personal loans. It also operates the Discover, Pulse, and Diners Club networks. The Discover network is the fourth-largest payment network in the United States as ranked by overall purchase volume, and Pulse is one of the largest ATM networks in the country.
<h3>Understanding the Numbers: Discover Financial servs's Finances</h3>
Market Capitalization Highlights: Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.
Revenue Growth: Discover Financial servs's revenue growth over a period of 3M has been noteworthy. As of 31 December, 2024, the company achieved a revenue growth rate of approximately 13.85%. This indicates a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Financials sector.
Net Margin: Discover Financial servs's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 26.98%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Discover Financial servs's ROE stands out, surpassing industry averages. With an impressive ROE of 7.8%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Discover Financial servs's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 0.86%, the company may face hurdles in achieving optimal financial performance.
Debt Management: Discover Financial servs's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.96.
<h2>The Basics of Analyst Ratings</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Discover Financial servs Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)

During the last three months, 6 analysts shared their evaluations of Eagle Materials (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EXP#NYSE">EXP</a>), revealing diverse outlooks from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $264.5, with a high estimate of $310.00 and a low estimate of $242.00. Observing a downward trend, the current average is 11.54% lower than the prior average price target of $299.00. 
<img src="https://www.benzinga.com/files/images/story/2025/1745532035_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
A clear picture of Eagle Materials's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Keith Hughes &#x7C;Truist Securities &#x7C;Lowers &#x7C;Buy &#x7C; $280.00&#x7C;$330.00 &#x7C; 
&#x7C;Garik Shmois &#x7C;Loop Capital &#x7C;Lowers &#x7C;Hold &#x7C; $245.00&#x7C;$280.00 &#x7C; 
&#x7C;Adrian Huerta &#x7C;JP Morgan &#x7C;Lowers &#x7C;Neutral &#x7C; $250.00&#x7C;$310.00 &#x7C; 
&#x7C;Brian Brophy &#x7C;Stifel &#x7C;Announces &#x7C;Hold &#x7C; $242.00&#x7C;- &#x7C; 
&#x7C;Brent Thielman &#x7C;DA Davidson &#x7C;Lowers &#x7C;Neutral &#x7C; $260.00&#x7C;$265.00 &#x7C; 
&#x7C;Trey Grooms &#x7C;Stephens &amp; Co. &#x7C;Maintains &#x7C;Overweight &#x7C; $310.00&#x7C;$310.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Eagle Materials. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Eagle Materials compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Eagle Materials's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Eagle Materials's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/EXP/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Eagle Materials analyst ratings.</a>
<h2>All You Need to Know About Eagle Materials</h2>
Eagle Materials Inc produces and sells construction products and building materials. Construction products include cement, slag, concrete, and aggregates and building materials include cement and gypsum wallboard, and are sold to the construction and building industries. The firm organizes itself into two sectors: Heavy Materials, which includes the Cement and Concrete and Aggregates segments, and Light Materials, which includes the Gypsum Wallboard and Recycled Paperboard segments.
<h3>Unraveling the Financial Story of Eagle Materials</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Negative Revenue Trend: Examining Eagle Materials's financials over 3M reveals challenges. As of 31 December, 2024, the company experienced a decline of approximately -0.14% in revenue growth, reflecting a decrease in top-line earnings. When compared to others in the Materials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Eagle Materials's net margin excels beyond industry benchmarks, reaching 21.43%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Eagle Materials's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 8.17% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Eagle Materials's ROA excels beyond industry benchmarks, reaching 3.88%. This signifies efficient management of assets and strong financial health.
Debt Management: Eagle Materials's debt-to-equity ratio surpasses industry norms, standing at 0.7. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>How Are Analyst Ratings Determined?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Demystifying Eagle Materials: Insights From 6 Analyst Reviews

In the last three months, 6 analysts have published ratings on Virtu Finl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIRT#NASDAQ">VIRT</a>), offering a diverse range of perspectives from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $38.33, with a high estimate of $48.00 and a low estimate of $28.00. Surpassing the previous average price target of $38.17, the current average has increased by 0.42%.
<img src="https://www.benzinga.com/files/images/story/2025/1745532025_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
The standing of Virtu Finl among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Alex Kramm &#x7C;UBS &#x7C;Raises &#x7C;Neutral &#x7C; $40.00&#x7C;$38.00 &#x7C; 
&#x7C;Michael Cyprys &#x7C;Morgan Stanley &#x7C;Raises &#x7C;Underweight &#x7C; $28.00&#x7C;$26.00 &#x7C; 
&#x7C;Kenneth Worthington &#x7C;JP Morgan &#x7C;Raises &#x7C;Neutral &#x7C; $39.00&#x7C;$37.00 &#x7C; 
&#x7C;Kaimon Chung &#x7C;Evercore ISI Group &#x7C;Raises &#x7C;In-Line &#x7C; $42.00&#x7C;$41.00 &#x7C; 
&#x7C;Craig Siegenthaler &#x7C;B of A Securities &#x7C;Lowers &#x7C;Buy &#x7C; $48.00&#x7C;$56.00 &#x7C; 
&#x7C;Michael Cyprys &#x7C;Morgan Stanley &#x7C;Raises &#x7C;Equal-Weight &#x7C; $33.00&#x7C;$31.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Virtu Finl. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Virtu Finl compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Virtu Finl's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Capture valuable insights into Virtu Finl's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/VIRT/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Virtu Finl analyst ratings.</a>
<h2>About Virtu Finl</h2>
Virtu Financial Inc is a financial firm that leverages cutting edge technology to deliver liquidity to the global markets and innovative, transparent trading solutions to its clients. The company's operating segment includes Market Making; and Execution Services. The non-operating segment of the company includes the Corporate segment. The company generates maximum revenue from the market-making segment. The Market Making segment principally consists of market-making in the cash, futures, and options markets across equities, options, fixed income, currencies, and commodities. Geographically, it derives a majority of its revenue from the United States and also has a presence in Ireland and Other Countries.
<h3>Key Indicators: Virtu Finl's Financial Health</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Growth: Virtu Finl displayed positive results in 3M. As of 31 December, 2024, the company achieved a solid revenue growth rate of approximately 55.66%. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Financials sector.
Net Margin: Virtu Finl's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of 10.6%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): Virtu Finl's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 7.11%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Virtu Finl's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 0.59%, the company may face hurdles in achieving optimal financial returns.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 4.55, caution is advised due to increased financial risk.
<h2>Analyst Ratings: Simplified</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Comments

BriaCell Therapeutics

BriaCell Therapeutics (BCTX) Options

Loading...

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL